Trump’s Lower Poll Numbers: People expect more than tough talk

I’ve cooled off a lot on Trump since he signed that stupid executive order on marijuana, and the damage for me is permanent.  Yet again, he got suckered by the health people into doing something terrible.  After he signed that order, the first thing I did was rip down all the campaign signs I had hanging in my garage, well over 50 of them, and throw them all away.  And for me, that’s significant. I’ve been a Trump person for over a decade now, and I even flew a Trump flag out in front of my house since 2020.  I’ve been there with him through everything.  But when it comes to pot, that’s my off-ramp, I can’t go there.  I remember the surge—the big‑arena rally electricity, the “we’re going to fix this” certainty, the promise that the swamp would finally feel handcuffs, not hashtags. Enthusiasm is an accelerant: it makes the first months of any administration think like a rocket, but governing is ballast. You can talk like an MMA weigh-in; then you hit the first year, and the levers don’t move like switches. You’re turning a tender boat into a heavy ship, and it doesn’t pivot just because the helmsman barks louder. That gap—between campaign voltage and governing torque—shows up in the numbers. As 2026 starts, the national trackers have Trump underwater: RealClearPolitics’ late‑December average had him at 43.4% approve, 53.3% disapprove; The Economist/YouGov and Gallup show similar or lower figures. Even outlets aggregating friendlier samples, like Trafalgar or InsiderAdvantage, only briefly nudge him above water. Net‑net, the public mood reflects a rollercoaster: from early‑term +2 net approval to roughly −10 to −18 through late December, with a modest tick up right at New Year’s. 1234

That swing—call it 15 to 18 points from honeymoon to grind—doesn’t surprise me. It maps to two realities people feel viscerally. First, the ceremonial ceiling of the presidency: Article II is not a crown. You can veto, you can appoint, you can persuade; prosecution runs through the Department of Justice and independent courts, not the Resolute Desk’s social media feed. Madison built it that way on purpose. Checks and balances are designed to slow action, to force coalition, to prevent any one figure from conducting government as a one-person show. That means even if a president wants a dramatic perp‑walk tomorrow, the machinery says: probable cause, grand jury, trial, appeal. The Constitution puts the brakes on rage. 567

Second, expectations on crime and corruption collided with the political physics of institutions. If you’ve got an FBI director, an Attorney General, and a thousand career AUSAs who live by procedure and fear appellate reversals, you won’t see “handcuffs by Friday.” That disconnect fuels voter irritation, especially among people like me who wanted visible consequences for government abuse. It’s why you can have weeks of tough talk about Somali fraud in Minnesota, accelerated federal deployments, and endless press hits—but arrests and convictions trail the rhetoric by months or years. And when the rhetoric goes nowhere, it bleeds support beyond the base. 8910

I don’t do the marijuana thing for anybody. For me, that EO was a line. It told me the posture was more New York live‑and‑let‑live than “law‑and‑order, no exceptions.” That order didn’t itself reschedule cannabis; it directed DOJ to expedite moving marijuana from Schedule I to Schedule III, completing a process that began under HHS/DEA in 2024. But the signal was unmistakable: prioritize medical research, loosen tax handcuffs on the industry, and press Congress to revisit hemp and CBD definitions—precisely the kind of conciliatory, technocratic reform that calms markets more than it excites the “no mercy for drug crime” crowd, which I certainly am.  I pulled the flags down in my garage that day and they’ll never go back up.  I’m not against Trump, but my excitement for them cooled off a lot, so much so that I don’t want to think about them every day as I walk through my garage, because they are embarrassing to me. 111213

Here’s the thing, though—and it’s the uncomfortable truth most voters gravitate toward regardless of culture‑war skirmishes: the economy is the scoreboard. If gas prices stabilize, if mortgage rates come off the boil, if you can finally buy a starter home because affordability improves, you forgive a lot. On the macro, there’s real movement. The BEA’s delayed report shows 3Q 2025 real GDP at a 4.3% annualized pace—the fastest in two years—following 3.8% in Q2. Final sales to private domestic purchasers rose 3.0%. Corporate profits jumped by $166.1B in the quarter. Inflation metrics ticked up (PCE 2.8%, core 2.9%), but not enough to erase the growth story. That’s the tail catching the dog’s head: policies set in early 2025 are working their way through the system, with the visible payoff likely in 2026–2027. 141516

Of course, growth isn’t a sermon; it’s cash flow after taxes, interest, and insurance. You feel it when payroll expands in your county, when inventory turns faster, when suppliers quote shorter lead times, and your WIP finally clears. That’s why a published GDP line doesn’t erase public skepticism—especially if unemployment has bumped or affordability still stings. Polling narratives underline the tension: by late December, news roundups cataloged affordability as Trump’s weak spot, even as GDP surprised to the upside. Voters want price relief and housing access more than they want a Nobel speech. 217

Meanwhile, the marijuana decision isn’t just polls—it’s a coalition test. Gallup shows an 88–90% supermajority supporting legalization at least for medical use, but a notable 2025 dip in Republican support for broader legalization (down to ~40%). So rescheduling to Schedule III threads a needle: it concedes medical utility, accelerates research, and removes the industry’s punitive 280E tax hit—without federal legalization. That satisfies some independents and seniors who want regulated access for pain or chemo‑nausea, but it irritates law-and-order conservatives who expected a crackdown. Politically, that move trades intensity for breadth; in approval math, it’s a mixed bag, and you can see it in the net‑negative trend lines. 1819

If the presidency is more persuasion than prosecution, the question becomes: what persuasion works? Voters forgive drama when the ledger smiles. A 4.3% quarter isn’t destiny, but if you string quarters of 3–5% growth, ease tariffs where they hurt consumers, and let rates drift down without spooking inflation, the swing back is real. You can see the early narrative already forming in coverage: growth beating forecasts, AI/data‑center investment underwriting business capex, exports up, and consumption resilient despite elevated prices—tempered by caution about labor market softness and a shutdown’s hangover. That says 2026 could indeed be the payoff year if the policy tailwinds don’t get clipped by court rulings, trade shocks, or an inflation relapse. 2021

But I won’t pretend the justice gap away. People voted for “accountability” as much as for “affordability.” When they hear weeks of talk about Somali fraud and see federal surge operations, but still don’t see high-level perp walks, they conclude the system protects itself. Some of the public rhetoric has been sloppy—fact‑checks have knocked down the “billions every year” and “90% Somali fraud” claims as overstatements. It’s precisely the kind of overreach that costs net approval points with suburban voters who want credibility even when they agree with the crackdown. 2210

So where am I? Cool‑off, yes. Vote, yes. Flags in the garage, gone. It’s the ledger test now. If 2026 delivers—tailwinds in GDP growth, price relief, and visible competence—then you’ll see that 18-point swing reverse itself. If the administration wants that faster, it needs a visible chain of successes: clean arrests that stick, targeted prosecutions that demonstrate competence, not vengeance, and a disciplined economic message focused on prices, housing, and small‑business cost of capital. Show justice without bluster, and deliver growth without gimmicks. Voters reward that more than they reward the pre-fight theatrics.

The ceremonial nature of the office remains a burden, and that’s by design. You can’t govern like a king—and you shouldn’t. But you can marshal DOJ’s independence with steadiness, not soundbites; you can turn the ship with patient torque, not wheel‑spins. If the heavy ship keeps turning, by late 2026, people will feel it in their household math before they see it in the polls. And then, ironically, the numbers that cooled the base will warm back up again, not because the tough talk got louder, but because the cash registers did.

—

Key data points (late 2025 / early 2026)

• Approval averages: RCP (Dec 1–30, 2025): 43.4% approve, 53.3% disapprove (−9.9 net). Gallup late Dec polls show around 36–41% approve, 54–61% disapprove. The Economist/YouGov: ~39–42% approve, 55–56% disapprove. Some polls (Trafalgar, InsiderAdvantage) show temporary +1 to +9 net, but the aggregate remains negative. 132

• GDP (Q3 2025): Real GDP +4.3% annualized; Q2 +3.8%. PCE price index +2.8% (core +2.9%). Corporate profits +$166.1B. Real final sales to private domestic purchasers +3.0%. 14

• Marijuana EO (Dec 18, 2025): Executive Order directs DOJ to expedite rescheduling marijuana to Schedule III; emphasizes medical research and signals hemp/CBD legislative fix. Rulemaking not yet final; rescheduling would not legalize cannabis federally. 1112

• Public opinion on marijuana: Pew Jan–Feb 2025: 54% legal for medical+recreational; 33% medical only; 12% not legal. Gallup Nov 2025: overall support for legalization at 64%, with GOP support declining to ~40%. 1819

• Minnesota Somali fraud rhetoric vs. facts: Administration rhetoric escalated; deployments announced; fact‑checks dispute claims of “billions every year” and broad‑brush culpability; investigations ongoing with mixed publicly verified figures. 8922

—

Footnotes

1. RealClearPolitics “President Trump Job Approval” composite showing 43.4% / 53.3% for Dec 2025 and recent daily poll mix. 1

2. CNN poll‑of‑polls listing individual late‑Dec 2025 surveys (Gallup 36/59; Fox 44/56; Quinnipiac 40/54; Reuters/Ipsos 39/59). 3

3. USA Today roundups summarizing end-of-year approval trackers and issue concerns (affordability, economy). 2

4. The Economist/YouGov approval tracker commentary on net approval trajectory in 2025. 4

5. U.S. Constitution analysis on separation of powers and checks/balances, outlining institutional limits on presidential prosecution influence. 56

6. BEA Q3 2025 GDP report: +4.3% annualized growth; PCE and profits details; delayed due to shutdown. 14

7. CNBC coverage of the same BEA release detailing PCE inflation and corporate profits. 15

8. Pew Research Center short read (July 8, 2025) on Americans and marijuana (medical vs. recreational support). 18

9. Gallup/Marijuana Moment reporting on 2025 legalization support and GOP decline. 19

10. White House Fact Sheet and JURIST explainer on the Dec 18 cannabis EO: expedite rescheduling; not self-executing; rulemaking required. 1112

11. USA Today/Politico/NBC coverage & PBS segment capturing Minnesota Somali controversy, federal surges, and pushback/fact‑checks. 8109

12. Pittsburgh Post-Gazette / FactCheck.org analysis debunking exaggerated claims on amounts and welfare percentages. 22

—

Bibliography & Further Reading

• BEA. “Gross Domestic Product, 3rd Quarter 2025 (Initial Estimate) and Corporate Profits (Preliminary).” Dec 23, 2025. 14

• CNN Polling. “President Trump’s approval ratings | CNN Politics.” Dec 2025. 3

• RealClearPolitics / RealClearPolling. “President Trump Job Approval” aggregates & latest polls pages. Dec 2025–Jan 2026. 123

• The Economist/YouGov. Interactive approval tracker and analysis. Dec 2025–Jan 2026. 4

• USA Today. “Trump approval rating ticks up as 2026 begins.” Jan 2–3, 2026. 224

• Pew Research Center. “9 facts about Americans and marijuana.” July 8, 2025. 18

• Marijuana Moment. “DOJ Could Ignore Trump’s Marijuana Rescheduling Directive…” Dec 29, 2025; “Marijuana Saw Some Big Moments in 2025…” Dec 30, 2025. 2513

• White House Fact Sheet. “President Donald J. Trump is Increasing Medical Marijuana and Cannabidiol Research.” Dec 18, 2025. 11

• JURIST. “Trump signs executive order to expedite marijuana rescheduling.” Dec 19, 2025. 12

• CNBC / CBS News. Coverage of Q3 GDP surprise and inflation details. Dec 23, 2025. 1516

• USA Today / Politico / NBC News / PBS. Somali community coverage, federal deployments, and fact‑checks. Dec 2025–Jan 2026. 8109

• Pittsburgh Post-Gazette / FactCheck.org. “Fact-checking Trump’s verbal attack on Minnesota’s Somali community.” Dec 10, 2025. 22

Rich Hoffman

Click Here to Protect Yourself with Second Call Defense https://www.secondcalldefense.org/?affiliate=20707